The series of new acetylenic thioquinolines containing propargyl, 4-chloro-2-butynyl, and 4-acyloxy-2- butynyl groups have been prepared and tested for antiproliferative activity in vitro against human [SW707 (colorectal adenocarcinoma), CCRF/CEM (leukemia), T47D (breast cancer)] and murine [P388 (leukemia), B16 (melanoma)] cancer lines. Most of the obtained compounds exhibited antiproliferative activity, especially compounds 8, 12, and 21 showed the ID50 values ranging from 0.4 to 3.8 μg/ml comparable to that of cisplatin used as reference compounds. © The Author(s) 2010.
CITATION STYLE
Boryczka, S., Mól, W., Milczarek, M., Wietrzyk, J., & Bȩbenek, E. (2011). Synthesis and in vitro antiproliferative activity of novel (4-chloro- and 4-acyloxy-2-butynyl)thioquinolines. Medicinal Chemistry Research, 20(8), 1402–1410. https://doi.org/10.1007/s00044-010-9495-y
Mendeley helps you to discover research relevant for your work.